Industry News Dupixent approved as targeted medicine for chronic spontaneous urticaria in the EU   PADCEV plus Keytruda approved for certain patients with bladder cancer Novartis receives FDA approval for Itvisma, a gene replacement therapy for patients two years and older with spinal muscular atrophy Lilly’s plans to open Lilly Gateway Labs site in Philadelphia   TESARO initiates litigation against AnaptysBio An Overview of Recent USP Bacterial Endotoxins Standards Development Astrazeneca’s Koselugo approved for adults with neurofibromatosis type 1 in the US GSK and LTZ announce collaboration to advance novel myeloid cell engagers in oncology   Bristol Myers Squibb receives approval to expand use of CAR T Cell Therapy Breyanzi for relapsed or refractory mantle cell lymphoma Strategies for Controlling the Quality of mRNA EPKINLY in combination with Rituximab and Lenalidomide approved for relapsed or refractory follicular lymphoma AstraZeneca’s $2 billion manufacturing investment in Maryland Upcoming Webinars